International Agency for Research on Cancer (2020) Latest global cancer data: Cancer burden rises to 19.3 million new cases. Press release N° 292. World Health Organization

Lundh MH, Lampic C, Nordin K, Ahlgren J, Bergkvist L, Lambe M et al (2013) Changes in health-related quality of life by occupational status among women diagnosed with breast cancer—a population-based cohort study. Psychooncology 22:2321–2331

Article  Google Scholar 

Cocchiara RA, Sciarra I, D’Egidio V, Sestili C, Mancino M, Backhaus I et al (2018) Returning to work after breast cancer: a systematic review of reviews. Work 61:463–476

Article  CAS  Google Scholar 

Arndt V, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R et al (2019) Return to work after cancer. A multi-regional population-based study from Germany. Acta Oncol Stockh Swed. 58:811–818

Article  Google Scholar 

Islam T, Dahlui M, Majid HA, Nahar AM, Mohd Taib NA, Su TT (2014) Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health 14:S8

Article  Google Scholar 

Sun W, Chen K, Terhaar A, Wiegmann DA, Heidrich SM, Tevaarwerk AJ et al (2016) Work-related barriers, facilitators, and strategies of breast cancer survivors working during curative treatment. Work Read Mass 55:783–795

Google Scholar 

Bijker R, Duijts SFA, Smith SN, de Wildt-Liesveld R, Anema JR, Regeer BJ (2018) Functional impairments and work-related outcomes in breast cancer survivors: a systematic review. J Occup Rehabil 28:429–451

Article  Google Scholar 

Gradishar WJ, Anderson BO, Abraham J, Aft R, Allison KH, Blair SL et al (2018) Breast Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 9 Oct 2018

de Boer AGEM (2014) The European Cancer and Work Network: CANWON. J Occup Rehabil 24:393–398

Article  Google Scholar 

Watanabe T, Kuranami M, Inoue K, Masuda N, Aogi K, Ohno S et al (2017) Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study. Cancer 123:759–768

Article  CAS  Google Scholar 

Ewertz M, Qvortrup C, Eckhoff L (2015) Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol Stockh Swed 54:587–591

Article  CAS  Google Scholar 

Lee JJ, Swain SM (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24:1633–1642

Article  CAS  Google Scholar 

Eckhoff L, Nielsen M, Moeller S, Knoop A (2011) TAXTOX—a retrospective study regarding the side effects of docetaxel given as part of the adjuvant treatment to patients with primary breast cancer in Denmark from 2007 to 2009. Acta Oncol Stockh Swed 50:1075–1082

Article  CAS  Google Scholar 

Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C et al (2012) A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res 18:5099–5109

Article  CAS  Google Scholar 

Boora GK, Kulkarni AA, Kanwar R, Beyerlein P, Qin R, Banck MS et al (2015) Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance). J Neurol Sci 357:35–40

Article  CAS  Google Scholar 

Eckhoff L, Feddersen S, Knoop AS, Ewertz M, Bergmann TK (2015) Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer. Acta Oncol Stockh Swed 54:530–537

CAS  Google Scholar 

Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S et al (2016) Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel. OncoTargets Ther 9:5073–5080

Article  CAS  Google Scholar 

Ahern TP, Collin LJ, Baurley JW, Kjærsgaard A, Nash R, Maliniak ML et al (2020) Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 29:582–590

Article  CAS  Google Scholar 

Howell A (2005) ATAC trial update. Lancet 365:1225–1226

Article  Google Scholar 

Schmidt M, Schmidt SAJ, Adelborg K, Sundbøll J, Laugesen K, Ehrenstein V et al (2019) The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol 11:563–591

Article  Google Scholar 

Schmidt M, Pedersen L, Sørensen HT (2014) The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 29:541–549

Article  Google Scholar 

Jensen M-B, Laenkholm A-V, Offersen BV, Christiansen P, Kroman N, Mouridsen HT et al (2018) The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007–2016. Acta Oncol 57:13–18

Article  Google Scholar 

Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L (2010) Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol 2:51–56

Article  Google Scholar 

Helweg-Larsen K (2011) The Danish Register of causes of death. Scand J Public Health 39(7 Suppl):26–29

Article  Google Scholar 

Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449–490

Article  Google Scholar 

Bliddal M, Broe A, Pottegård A, Olsen J, Langhoff-Roos J (2018) The Danish medical birth register. Eur J Epidemiol 33:27–36

Article  Google Scholar 

Jensen VM, Rasmussen AW (2011) Danish education registers. Scand J Public Health 39(7 Suppl):91–94

Article  Google Scholar 

Baadsgaard M, Quitzau J (2011) Danish registers on personal income and transfer payments. Scand J Public Health 39(7_suppl):103–105

Article  Google Scholar 

Andersen TM, Svarer M (2007) Flexicurity—labour market performance in Denmark*. CESifo Econ Stud 53:389–429

Article  Google Scholar 

Hjollund NH, Larsen FB, Andersen JH (2007) Register-based follow-up of social benefits and other transfer payments: accuracy and degree of completeness in a Danish interdepartmental administrative database compared with a population-based survey. Scand J Public Health 35:497–502

Article  Google Scholar 

Collin LJ, Cronin-Fenton DP, Ahern TP, Christiansen PM, Damkier P, Ejlertsen B et al (2018) Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark. BMJ Open. https://doi.org/10.1136/bmjopen-2018-021805

Article  Google Scholar 

Ejlertsen B, Tuxen MK, Jakobsen EH, Jensen M-B, Knoop AS, Højris I et al (2017) Adjuvant cyclophosphamide and docetaxel with or without epirubicin for early TOP2A-normal breast cancer: DBCG 07-READ, an open-label, phase III, randomized trial. J Clin Oncol 35:2639–2646

Article  CAS  Google Scholar 

Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434–443

Article  CAS  Google Scholar 

Rasmus R, Chih W, Kristian K, Fosbøl EL, Mogensen UM, Lamberts M et al (2016) Return to the workforce after first hospitalization for heart failure. Circulation 134:999–1009

Article  Google Scholar 

Kristian K, Mads W, Normark MR, Kirsten F, Eggert JS, Shahzleen R et al (2015) Return to work in out-of-hospital cardiac arrest survivors. Circulation 131:1682–1690

Article  Google Scholar 

Evers PD, Farkas DK, Hjorth CF, Khoury M, Olsen M, Madsen NL (2021) Return to work following adverse cardiovascular events in adults with congenital heart disease. Int J Cardiol Congenit Heart Dis 4:100160

Article  Google Scholar 

Biering K, Hjøllund NH, Lund T (2013) Methods in measuring return to work: a comparison of measures of return to work following treatment of coronary heart disease. J Occup Rehabil 23:400–405

Article  Google Scholar 

Amin MB, American Joint Committee on Cancer, American Cancer Society, editors (2017) AJCC cancer staging manual. Eight edition / editor-in-chief, Mahul B. Amin, MD, FCAP ; editors, Stephen B. Edge, MD, FACS [and 16 others] ; Donna M. Gress, RHIT, CTR-Technical editor ; Laura R. Meyer, CAPM-Managing editor. American Joint Committee on Cancer, Springer, Chicago

Rothman KJ, Lash T, Greenland S (2012) Modern Epidemiology. Third edition. Philadelphia Baltimore New York London Buenos Aires Hong Kong Sydney Tokyo: LWW

Kollerup A, Ladenburg J, Heinesen E, Kolodziejczyk C (2021) The importance of workplace accommodation for cancer survivors—the role of flexible work schedules and psychological help in returning to work. Econ Hum Biol 43:101057

Article  Google Scholar 

Baker SD, Verweij J, Cusatis GA, van Schaik R, Marsh S, Orwick SJ et al (2009) Pharmacogenetic pathway analysis of docetaxel elimination. Clin Pharmacol Ther 85:155–163

Article  CAS  Google Scholar 

Leskelä S, Jara C, Leandro-García LJ, Martínez A, García-Donas J, Hernando S et al (2011) Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity. Pharmacogenomics J 11:121–129

Article  Google Scholar 

Eckhoff L, Knoop A, Jensen MB, Ewertz M (1990) Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur J Cancer Oxf Engl 2015(51):292–300

Google Scholar 

Argyriou AA, Polychronopoulos P, Iconomou G, Koutras A, Kalofonos HP, Chroni E (2005) Paclitaxel plus carboplatin–induced peripheral neuropathy: a prospective clinical and electrophysiological study in patients suffering from solid malignancies. J Neurol 252:1459–1464

Article  CAS  Google Scholar 

Cronin-Fenton DP, Kjærsgaard A, Ahern TP, Mele M, Ewertz M, Hamilton-Dutoit S et al (2017) Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study. Acta Oncol 56:1155–1160

Article  Google Scholar 

Jensen AR, Storm HH, Møller S, Overgaard J (2003) Validity and representativity in the Danish Breast Cancer Cooperative Group—a study on protocol allocation and data validity from one county to a multi-centre database. Acta Oncol Stockh Swed 42:179–185

Article  Google Scholar 

Stapelfeldt CM, Jensen C, Andersen NT, Fleten N, Nielsen CV (2012) Validation of sick leave measures: self-reported sick leave and sickness benefit data from a Danish national register compared to multiple workplace-registered sick leave spells in a Danish municipality. BMC Public Health 12:661

Article  Google Scholar 

Salanti G, Amountza G, Ntzani EE, Ioannidis JPA (2005) Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet EJHG 13:840–848

Article  CAS  Google Scholar 

Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J (2008) How should we use information about HWE in the meta-analyses of genetic association studies? Int J Epidemiol 37:136–146

Article